TMCnet33m
InspireMD and NAMSA to Partner on CGUARDIANS II Pivotal Clinical Trial of the CGuard Prime™ 80 cm Carotid Stent System for Use in TCAR procedures
On December 9, 2024, InspireMD announced that the first patient had been enrolled into the CGUARDIANS II clinical study.
manilatimes44m
Veru Reports Fiscal 2025 First Quarter Financial Results and Clinical Program Progress
The Independent Data Monitoring Committee met this week on February 10, 2025 to evaluate the unblinded safety Phase 2b QUALITY data and recommended to continue the QUALITY extension study as designed- ...
TMCnet54m
Agios Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights
Research and Development (R&D) Expenses: R&D expenses were $82.8 million for the fourth quarter of 2024, compared to $77.5 million for the fourth quarter of 2023, and $301.3 million for the full year ...